Gunda Telsnigg-Pristauz
Feldbach, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 25, 2026
Correction: Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer.
Journal: Breast cancer research and treatment
Published: February 18, 2026
Austrian treatment algorithms 2025: CDK 4/6 inhibitors in the adjuvant therapy of HR+/HER2- early breast cancer.
Journal: Wiener klinische Wochenschrift
Published: February 09, 2026
High-grade serous ovarian cancer is associated with increased TP53 mutation burden in uterine lavage.
Journal: NPJ precision oncology
Published: January 27, 2026
Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 27, 2025
Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer.
Journal: Breast cancer research and treatment
Published: March 05, 2024
Management of Third and Fourth-Degree Perineal Tears After Vaginal Birth. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/079, December 2020).
Journal: Geburtshilfe und Frauenheilkunde
Published: August 17, 2022
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 07, 2022
Vaginal laser therapy versus hyaluronic acid suppositories for women with symptoms of urogenital atrophy after treatment for breast cancer: A randomized controlled trial.
Journal: Maturitas
Published: December 10, 2021
Combined Mastectomy and Laparoscopic Hysterectomy with Salpingo-Oophorectomy in Transgender Men: a Cohort Study.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: April 15, 2021
COVID-19 During Pregnancy and Puerperium - A Review by the Austrian Society of Gynaecology and Obstetrics (OEGGG).
Journal: Geburtshilfe und Frauenheilkunde
Published: May 19, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026